257 related articles for article (PubMed ID: 25835356)
1. New heterocyclic compounds: Synthesis and antitrypanosomal properties.
Pomel S; Dubar F; Forge D; Loiseau PM; Biot C
Bioorg Med Chem; 2015 Aug; 23(16):5168-74. PubMed ID: 25835356
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei.
Hiltensperger G; Jones NG; Niedermeier S; Stich A; Kaiser M; Jung J; Puhl S; Damme A; Braunschweig H; Meinel L; Engstler M; Holzgrabe U
J Med Chem; 2012 Mar; 55(6):2538-48. PubMed ID: 22376072
[TBL] [Abstract][Full Text] [Related]
3. Spiroarsoranes of second generation: evaluation of trypanocidal properties against Trypanosoma brucei brucei.
Loiseau PM; Wolf JG; Gayral P
Trop Med Parasitol; 1993 Mar; 44(1):32-6. PubMed ID: 8516630
[TBL] [Abstract][Full Text] [Related]
4. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
[TBL] [Abstract][Full Text] [Related]
5. Fluorine walk: The impact of fluorine in quinolone amides on their activity against African sleeping sickness.
Berninger M; Erk C; Fuß A; Skaf J; Al-Momani E; Israel I; Raschig M; Güntzel P; Samnick S; Holzgrabe U
Eur J Med Chem; 2018 May; 152():377-391. PubMed ID: 29742443
[TBL] [Abstract][Full Text] [Related]
6. Trioxaferroquines as new hybrid antimalarial drugs.
Bellot F; Coslédan F; Vendier L; Brocard J; Meunier B; Robert A
J Med Chem; 2010 May; 53(10):4103-9. PubMed ID: 20443628
[TBL] [Abstract][Full Text] [Related]
7. Benzimidazole inhibitors of the major cysteine protease of
Pereira GA; Santos LH; Wang SC; Martins LC; Villela FS; Liao W; Dessoy MA; Dias LC; Andricopulo AD; Costa MA; Nagem RA; Caffrey CR; Liedl KR; Caffarena ER; Ferreira RS
Future Med Chem; 2019 Jul; 11(13):1537-1551. PubMed ID: 31469332
[No Abstract] [Full Text] [Related]
8. Synthesis and tripanocidal activity of ferrocenyl and benzyl diamines against Trypanosoma brucei and Trypanosoma cruzi.
Velásquez AM; Francisco AI; Kohatsu AA; Silva FA; Rodrigues DF; Teixeira RG; Chiari BG; de Almeida MG; Isaac VL; Vargas MD; Cicarelli RM
Bioorg Med Chem Lett; 2014 Apr; 24(7):1707-10. PubMed ID: 24630563
[TBL] [Abstract][Full Text] [Related]
9. Pharmacomodulations on new organometallic complexes of Ir, Pt, Rh, Pd, Os: in vitro and in vivo trypanocidal study against Trypanosoma brucei brucei.
Loiseau PM; Craciunescu DG; Doadrio-Villarejo JC; Certad-Fombona G; Gayral P
Trop Med Parasitol; 1992 Jun; 43(2):110-4. PubMed ID: 1519021
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro antitrypanosomal evaluation of novel 6-heteroarylidene-substituted quinolone derivatives.
Angula KT; Legoabe LJ; Swart T; Hoppe HC; Beteck RM
Eur J Med Chem; 2022 Jan; 227():113913. PubMed ID: 34656043
[TBL] [Abstract][Full Text] [Related]
11. A novel microwave synthesis of quinoline-3-carboxylic acid derivatives for treatment against human African trypanosomiasis.
Samant BS; Nyangari N
Mol Divers; 2012 Nov; 16(4):685-95. PubMed ID: 23054534
[TBL] [Abstract][Full Text] [Related]
12. Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents.
Qiao Z; Wang Q; Zhang F; Wang Z; Bowling T; Nare B; Jacobs RT; Zhang J; Ding D; Liu Y; Zhou H
J Med Chem; 2012 Apr; 55(7):3553-7. PubMed ID: 22360533
[TBL] [Abstract][Full Text] [Related]
13. Novel symmetric bis-benzimidazoles: Synthesis, DNA/RNA binding and antitrypanosomal activity.
Popov AB; Stolić I; Krstulović L; Taylor MC; Kelly JM; Tomić S; Tumir L; Bajić M; Raić-Malić S
Eur J Med Chem; 2019 Jul; 173():63-75. PubMed ID: 30986572
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cryptolepine and huperzine derivatives as lead compounds towards new agents for the treatment of human African trypanosomiasis.
Oluwafemi AJ; Okanla EO; Camps P; Muñoz-Torrerob D; Mackey ZB; Chiang PK; Seville S; Wright CW
Nat Prod Commun; 2009 Feb; 4(2):193-8. PubMed ID: 19370921
[TBL] [Abstract][Full Text] [Related]
15. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.
Huang TL; Bacchi CJ; Kode NR; Zhang Q; Wang G; Yartlet N; Rattendi D; Londono I; Mazumder L; Vanden Eynde JJ; Mayence A; Donkor IO
Int J Antimicrob Agents; 2007 Dec; 30(6):555-61. PubMed ID: 17920820
[TBL] [Abstract][Full Text] [Related]
16. Activity of Aromathecins against African Trypanosomes.
Nenortas NP; Cinelli MA; Morrell AE; Cushman M; Shapiro TA
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104277
[TBL] [Abstract][Full Text] [Related]
17. Indole and Benzimidazole Bichalcophenes: Synthesis, DNA Binding and Antiparasitic Activity.
Farahat AA; Ismail MA; Kumar A; Wenzler T; Brun R; Paul A; Wilson WD; Boykin DW
Eur J Med Chem; 2018 Jan; 143():1590-1596. PubMed ID: 29126729
[TBL] [Abstract][Full Text] [Related]
18. 9- and 11-Substituted 4-azapaullones are potent and selective inhibitors of African trypanosoma.
Maiwald F; Benítez D; Charquero D; Dar MA; Erdmann H; Preu L; Koch O; Hölscher C; Loaëc N; Meijer L; Comini MA; Kunick C
Eur J Med Chem; 2014 Aug; 83():274-83. PubMed ID: 24973661
[TBL] [Abstract][Full Text] [Related]
19. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
[TBL] [Abstract][Full Text] [Related]
20. Antiprotozoal activity of ferroquine.
Pomel S; Biot C; Bories C; Loiseau PM
Parasitol Res; 2013 Feb; 112(2):665-9. PubMed ID: 23229318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
